Schering-Plough
SGP
#530
Rank
NZ$79.37 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: NZ$3.52 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of NZ$3.52 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008NZ$3.52 B
2006NZ$2.54 B198.39%
2005NZ$0.85 B-395.83%
2004-NZ$0.29 Billion265.22%
2003-NZ$79.06 Million-102.01%
2002NZ$3.93 B3.62%
2001NZ$3.79 B-5.39%
2000NZ$4.01 B
1998NZ$3.31 B22.34%
1997NZ$2.70 B38.9%
1996NZ$1.94 B